Phase 3 trial of leniolisib in activated PI3Kδ syndrome, dabrafenib plus trametinib in relapsed/refractory hairy cell leukemia, and TγδLGL leukemia as a more symptomatic subset of leukemia
Blood Podcast
00:00
Introduction
Learn more about the efficacy and safety of Dabrafenib plus Trometinib in Relapsed Refractory B-RAP-V600E mutation positive Harry Celukemia. Review the findings from a study conducted in an international cohort of patients with T-gamma-Delta-LGL-lukemia.
Transcript
Play full episode
